매사추세츠의 크론병 임상 시험
크론병 관련 연구 27개가 매사추세츠 내 여러 지역에서 참여자를 모집하고 있습니다.
매사추세츠의 도시
공식 연구 텍스트(영어)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Massachusetts General Hospital-Crohn's and Colitis Center ( Site 5037), Boston
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Lucida Clinical Trials /ID# 282000, New Bedford
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT07697456Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
- Massachusetts General Hospital, Boston
피험자 모집 중건강한 지원자 환영
18세 ~ 75세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT07033208A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastro Health Research - Framingham, Framingham
- Lucida Clinical Trials LLC, New Bedford
피험자 모집 중4상
18세 ~ 80세 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT06581328A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Boston Childrens Hospital, Boston
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05923073Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Lucida Clinical Trials /ID# 266548, New Bedford
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Lucida Clinical Trials, New Bedford
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07499232Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Lucida Clinical Trials, New Bedford
피험자 모집 중3상
18세 ~ 70세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06937099Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Tufts Medical Center-Site Number: 8400126, Boston
- UMass Memorial Medical Center-Site Number: 8400121, Worcester
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07184931A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Massachusetts General Hospital - Mass General Waltham /ID# 255767, Waltham
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT05995353A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Boston Children's Hospital, Boston
- Massachusetts General Hospital, Waltham
피험자 모집 중3상
2세 ~ 19세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT04844606A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Boston Children's Hospital, Boston
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT05509777Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- Brigham and Women's Hospital, Boston
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT07237516Low Dose IL-2 for the Treatment of Crohn's Disease
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
피험자 모집 중1/2상
12세 ~ 80세 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT04263831Cranberry and Gut Health in Crohn's Disease
- UMASS medical center, Worcester
피험자 모집 중초기 1상
18세 ~ 65세 · 모든 성별 · 2026. 7. 20. 업데이트됨 · NCT07170462Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
- Boston Children's Hospital /ID# 262191, Boston
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 6. 24. 업데이트됨 · NCT06332534Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Boston Children's Hospital, Boston
피험자 모집 중4상
6세 ~ 17세 · 모든 성별 · 2026. 5. 27. 업데이트됨 · NCT05781152A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Boston Children's Hospital, Boston
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 5. 5. 업데이트됨 · NCT04779320Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Lucida Clinical Trials, LLC, New Bedford
- University of Massachusetts, Worcester, Worcester
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 4. 27. 업데이트됨 · NCT06456593A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400022, Boston
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 3. 27. 업데이트됨 · NCT06958536Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown
피험자 모집 중관찰 연구
18세 ~ 99세 · 모든 성별 · 2026. 3. 12. 업데이트됨 · NCT06252493Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
- Massachusetts General Hospital, Boston
피험자 모집 중건강한 지원자 환영
14세 이상 · 모든 성별 · 2026. 1. 30. 업데이트됨 · NCT05332639A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule
- Massachusetts General Hospital, Boston
피험자 모집 중건강한 지원자 환영
18세 ~ 75세 · 모든 성별 · 2025. 12. 16. 업데이트됨 · NCT07219537Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- Boston Children's Hospital, Boston
피험자 모집 중관찰 연구건강한 지원자 환영
13세 ~ 20세 · 모든 성별 · 2025. 10. 30. 업데이트됨 · NCT04508088High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
- Boston Children's Hospital, Boston
피험자 모집 중관찰 연구
5세 ~ 25세 · 모든 성별 · 2025. 3. 3. 업데이트됨 · NCT04331639Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
- Massachusetts General Hospital, Boston
피험자 모집 중관찰 연구건강한 지원자 환영
14세 이상 · 모든 성별 · 2024. 12. 20. 업데이트됨 · NCT06655415ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.